|
ZNF117 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.999840E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.859300E-03 |
| Normal-vs-Stage2 |
7.536000E-01 |
| Normal-vs-Stage3 |
4.718400E-01 |
| Normal-vs-Stage4 |
2.030100E-02 |
| Stage1-vs-Stage2 |
1.397820E-01 |
| Stage1-vs-Stage3 |
1.123180E-01 |
| Stage1-vs-Stage4 |
3.171000E-01 |
| Stage2-vs-Stage3 |
7.970400E-01 |
| Stage2-vs-Stage4 |
7.322300E-02 |
| Stage3-vs-Stage4 |
6.235800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.799550E-02 |
| Normal-vs-AfricanAmerican |
6.971700E-02 |
| Normal-vs-Asian |
1.459430E-01 |
| Caucasian-vs-AfricanAmerican |
2.904000E-01 |
| Caucasian-vs-Asian |
9.087000E-01 |
| AfricanAmerican-vs-Asian |
2.987600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.174300E-02 |
| Normal-vs-Female |
2.130000E-02 |
| Male-vs-Female |
7.840400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.116100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.410220E-01 |
| Normal-vs-Age(61-80Yrs) |
2.880800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.136000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.204420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.994160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.518500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.400600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.999800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.950350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.226000E-01 |
| Classical-VS-Follicular |
2.237099999991E-05 |
| Classical-VS-Other |
9.262200E-01 |
| Classical-VS-Normal |
6.003300E-04 |
| Tall-VS-Follicular |
8.455500E-02 |
| Tall-VS-Other |
5.041000E-01 |
| Tall-VS-Normal |
2.317400E-01 |
| Follicular-VS-Other |
1.168040E-01 |
| Follicular-VS-Normal |
3.344400E-01 |
| Other-VS-Normal |
1.151210E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.448200E-01 |
| Normal-vs-N1 |
7.835800E-03 |
| N0-vs-N1 |
2.346100E-02 |
|
|
